Magnetic resonance imaging (MRI) of the brain is a powerful diagnostic tool that allows healthcare providers to visualize the structures of the central nervous system in high detail. Unlike standard X-rays or computed tomography (CT) scans, an MRI uses powerful magnetic fields and radio waves to create clear images of soft tissues, white matter, and deep brain structures. It plays an essential role in diagnosing, monitoring, and understanding a wide range of neurological conditions [2], [3], [5].
Role of MRI in Multiple Sclerosis Diagnosis and Management
MRI plays a central role in the diagnosis and ongoing management of multiple sclerosis (MS), a chronic disease characterized by inflammation, demyelination, and neurodegeneration [2], [3]. Because many neurological conditions can produce white matter lesions that mimic MS, accurate imaging interpretation is critical [3]. Diagnostic frameworks like the McDonald criteria rely heavily on specific MRI findings—such as T2-weighted lesions, chronic black holes, and brain tissue atrophy—to confirm a diagnosis [3]. Emerging imaging biomarkers, including the central vein sign and paramagnetic rim lesions, have been integrated into updated diagnostic criteria to help clinicians differentiate MS from mimicking conditions with greater specificity [2], [3], [8]. Standardized brain protocols typically involve 3D FLAIR sequences, diffusion-weighted imaging, and specialized susceptibility-sensitive sequences to capture these subtle features [8].
Evaluating Movement Disorders and Parkinsonism
Brain imaging is frequently indicated when patients present with movement disorders, helping clinicians distinguish between conditions with overlapping symptoms, such as Parkinson's disease (PD) and progressive supranuclear palsy (PSP) [4], [6]. Advanced MRI techniques can reveal specific structural changes, such as the loss of normal anatomical markers in the substantia nigra (like the swallow-tail sign) and volume reductions in specific brain regions [6]. While structural ratios and indices are studied to aid differential diagnosis in movement disorders, specialized multiparameter imaging protocols continue to be evaluated for their ability to provide reliable biological indicators of disease progression [4], [6].
Detecting Rare Complications and Late Effects
Beyond chronic neurodegenerative diseases, brain MRI is instrumental in investigating acute or delayed neurological complications. For example, in rare conditions like stroke-like migraine attacks after radiation therapy (SMART) syndrome—a delayed complication that can occur years after cranial irradiation—MRI helps identify transient, reversible cortical abnormalities in previously irradiated brain regions [1]. When patients present with acute symptoms such as seizures, confusion, or focal neurological deficits, an MRI can help rule out structural changes or new focal lesions, guiding further clinical workups alongside tools like electroencephalography [1].
Tracking Disease Progression and Brain Volumetry
In addition to spotting initial lesions, MRI-based brain volumetry is increasingly utilized in clinical settings to measure changes in brain volume over time across various neurological conditions [5]. Quantitative measurements of regional brain atrophy serve as valid biomarkers that reflect underlying disease mechanisms, track clinical progression, and assist in monitoring potential treatment effects, particularly in conditions like Alzheimer's disease and multiple sclerosis [5].